Gulisa Turashvili

Sinai Health System

Papers

1

Total Citations

224

H-Index

1

About

Gulisa Turashvili is a leading pathologist whose research focuses on gynecologic cancers, particularly endometrial and ovarian malignancies, with an emphasis on improving surgical staging and diagnostic accuracy. Her major contributions include landmark work on sentinel lymph node biopsy (SLNB) in endometrial cancer, most notably her 2020 study "Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging," which has garnered 224 citations. This research critically examined whether SLNB using indocyanine green could replace traditional lymphadenectomy for surgical staging in high-grade endometrial cancer, providing essential evidence on diagnostic accuracy and morbidity outcomes. Turashvili's work has significantly influenced clinical practice by helping to refine staging protocols and reduce surgical complications. Her research is widely cited, reflecting its substantial impact on oncology and surgical pathology. Additionally, she has contributed to studies on ovarian cancer biomarkers and molecular classification of endometrial tumors, further advancing precision medicine in gynecologic oncology. Through her rigorous investigations, Turashvili continues to shape evidence-based guidelines and improve patient care in women's cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
224
Total Citations
224
Avg Citations/Paper
🏆 Most Cited Paper
Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
224 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Sinai Health System

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago